Replicate Bioscience
Hunter Little has worked in the biotechnology industry since 2016. Hunter began their career at Agilent Technologies as a Research Associate, and then moved to Poseida Therapeutics, Inc. in 2019, where they held the roles of Research Associate and Research Associate II. In 2022, Hunter Little joined Replicate Bioscience, Inc. as a Principal Associate Scientist.
Hunter Little attended California Polytechnic State University-San Luis Obispo from 2012 to 2016 and earned a Bachelor of Science in Biochemistry and Molecular Biology.
Replicate Bioscience
Replicate Bioscience is applying advanced srRNA technology towards solving a life-threatening problem—drug resistance in cancers—using their proprietary synthetic immune lethality approach. They are also developing srRNA injections for sustained therapeutic protein expression, to treat inflammatory disorders and other conditions.